Tengjun Biotechnology (TJBH) 10-Q 19 Aug 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Jun. 30, 2014	Aug. 15, 2014
Document And Entity Information	'	'
Entity Registrant Name	'China Herb Group Holdings Corp	'
Entity Central Index Key	'0001499785	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Document Type	'10-Q	'
Document Period End Date	30-Jun-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	36,443,119

Balance_Sheets

Balance Sheets (USD $)	Jun. 30, 2014	Dec. 31, 2013
CURRENT ASSETS:	'	'
Cash and cash equivalents	$2,202	$32,143
Prepaid expenses	30,000	'
TOTAL CURRENT ASSETS	32,202	32,143
TOTAL ASSETS	32,202	32,143
CURRENT LIABILITIES:	'	'
Accounts payable	5,353	450
Shareholder loans	77,200	20,000
TOTAL CURRENT LIABILITIES	82,553	20,450
STOCKHOLDER'S EQUITY (DEFICIT)	'	'
Preferred stock, $.001 par value, 5,000,000 shares authorized, 0 shares issued and outstanding	'	'
Common stock, $.001 par value, 75,000,000 shares authorized, 36,443,119 shares issued and outstanding June 30, 2014 and December 31, 2013	36,443	36,443
Additional paid-in capital	102,270	99,483
Accumulated deficit	-189,064	-124,233
TOTAL STOCKHOLDER'S EQUITY (DEFICIT)	-50,351	11,693
TOTAL LIABILITIES AND STOCKHOLDER'S EQUITY (DEFICIT)	$32,202	$32,143

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]	'	'
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par Value	$0.00	$0.00
Common Stock, Shares Authorized	75,000,000	75,000,000
Common Stock, Shares Issued	36,443,119	36,443,119
Common Stock, Shares Outstanding	36,443,119	36,443,119

Statements_of_Operations_Unaud

Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Statement of Operations [Abstract]	'	'	'	'
Revenues	'	'	'	'
Operating Expenses:	'	'	'	'
General and administrative	'	'	16,962	'
Legal fees	3,765	'	5,803	'
Accounting fees	1,000	1,000	20,500	4,000
Transfer agent fees	179	'	1,279	'
Consulting fees	'	'	12,000	'
Travel	'	'	4,500	'
Website	'	'	1,000	'
Total Operating Expenses	4,944	1,000	62,044	4,000
Loss from Operations	-4,944	-1,000	-62,044	-4,000
Other Expenses:	'	'	'	'
Interest expense	-1,700	'	-2,787	'
Total Other Expense	-1,700	'	-2,787	'
Net Loss	($6,644)	($1,000)	($64,831)	($4,000)
Net loss per common share, basic and diluted	'	'	'	'
Weighted average number of common shares outstanding:	'	'	'	'
Basic and diluted	36,443,119	4,300,000	36,443,119	4,300,000

Statements_of_Cash_Flow_Unaudi

Statements of Cash Flow (Unaudited) (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
OPERATING ACTIVITIES:	'	'
Net Loss	($64,831)	($4,000)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Imputed interest on related party loan	2,787	'
Changes in operating assets and liabilities:	'	'
(Increase) in prepaid expenses	-30,000	'
Increase (decrease) in accounts payable	4,903	'
NET CASH USED IN OPERATING ACTIVITIES	-87,141	-4,000
FINANCING ACTIVITIES:	'	'
Proceeds from loan from officer	57,200	4,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	57,200	4,000
NET CHANGE IN CASH	-29,941	'
Cash, beginning of period	32,143	'
Cash, end of period	2,202	'
SUPPLEMENTAL DISCLOSURES:	'	'
Interest paid	'	'
Income taxes paid	'	'

Organization

Organization	6 Months Ended
	Jun. 30, 2014
Organization [Abstract]	'
Organization	'
	NOTE 1 – Organization
	China Herb Group Holdings Corporation (“Company”) is a development stage company with minimal operations. The Company was incorporated under the name “Island Radio, Inc” under the laws of the State of Nevada on June 28, 2010. The Company’s plan of operations is to evaluate various industries, geographic and market opportunities. This may take the form of acquiring a business, being acquired by an existing business or developing a business organically. Any such efforts may require significant capital, which the Company currently lacks. There is no assurance that any such opportunity will become available. There is also no assurance that, if any opportunity becomes available, the Company will have the financial and other resources available to take advantage of such opportunity, since the Company’s has extremely limited liquidity.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2014
Summary of Significant Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	NOTE 2 – Summary of Significant Accounting Policies
	Unaudited Interim Financial Information
	The accompanying balance sheets as of June 30, 2014 and December 31, 2013, statements of operations for the three and six months ended June 30, 2014 and 2013, and the statements of cash flows for the six months ended June 30, 2014 and 2013 are unaudited. These unaudited interim financial statements have been prepared in accordance with accounting principles accepted in the United States of America (“GAAP”). In the opinion of the Company’s management, the unaudited interim financial statements have been prepared on the same basis as the audited financial statements and included all adjustments necessary for the fair presentation of the Company’s statement of financial position at June 30, 2014 and its results of operations and its cash flows for the period ended June 30, 2014. The results for the period ended June 30, 2014 are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2014.
	Basis of Presentation
	The accompanying financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (US GAAP) for financial information and in accordance with the Securities and Exchange Commission’s (SEC) Regulation S-X. They reflect all adjustments which are, in the opinion of the Company’s management, necessary for a fair presentation of the financial position and operating results as of and for the three and six months ended June 30, 2014, and 2013.
	Use of Estimates
	The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates.
	Cash and Cash Equivalents
	For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. As of June 30, 2014, and December 31, 2013 the Company had no cash equivalents.
	Fair Value of Financial Instruments
	ASC 820, “Fair Value Measurements” and ASC 825, Financial Instruments, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value:
	Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
	Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
	As of June 30, 2014 and December 31, 2013 we believe that the recorded values of all of our financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.
	Description	Level 1	Level 2	Level 3	Total Realized Loss
	30-Jun-14	-	-	-	-
	31-Dec-13	-	-	-	-
	Totals	-	-	-	-
	Net Loss per Share Calculation
	Basic net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per shares is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. During the three and six month periods ended June 30, 2014 and 2013, the Company had no dilutive financial instruments issued or outstanding.
	Income Taxes
	The Company accounts for income taxes pursuant to FASB ASC 740, Income Taxes. Under FASB ASC 740-10-25, deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences.
	The Company maintains a valuation allowance with respect to deferred tax assets. China Herb Group Holdings Corporation establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws.
	Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about its ability to realize the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.
	Prepaid Expenses
	Prepaid expenses relates to cash paid in advance for legal services. These amounts are recognized as expense over the service period.
	Fiscal Year
	The Company elected December 31st for its fiscal year end.

Going_Concern

Going Concern	6 Months Ended
	Jun. 30, 2014
Going Concern [Abstract]	'
Going Concern	'
	NOTE 3 – Going Concern
	The Company has minimal operations, and as such has devoted most of its efforts since its inception to developing its business plan, issuing common stock, attempting to raise capital, establishing its accounting systems and other administrative functions.
	As of June 30, 2014, the Company had $2,202 in cash. The Company is seeking sources of funding. Without limiting its available options, future equity financings will most likely be through the sale of additional shares of its common stock. It is possible that the Company could also offer warrants, options and/or rights in conjunction with any future issuances of its common stock. However, the Company can give no assurance that financing will be available to it, and if available, in amounts or on terms acceptable to the Company.
	The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United State of America, which contemplate continuation of the Company as a going concern. The Company has not established a source of revenues sufficient to cover its operating costs, and as such, has incurred an operating loss since its inception. Further, as of June 30, 2014, the Company had an accumulated deficit of ($189,064). These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments or classifications that may result from the possible inability of the Company to continue as a going concern.

Related_Party_Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	NOTE 4 – Related Party Transactions
	Shareholder loans
	During the year ended December 31, 2013, Chin Yung Kong, the director and shareholder of the Company, advanced $20,000 to the Company for working capital purposes. These working capital advances of $20,000 are payable on demand and, at June 30, 2014 and December 31, 2013, reflected as shareholder loans on the accompanying balance sheets.
	During the six months ended June 30, 2014, Qiuping Lu, President, CEO, director and shareholder of the Company, advanced $57,200 for Company for working capital purposes. These working capital advances of $57,200 are payable on demand and are reflected as shareholder loans on the accompanying balance sheet. During the three and six months ended June 30, 2014, the Company imputed interest of $1,700 and $2,787 and recorded interest expense and an increase in paid- in capital.

Common_Stock

Common Stock	6 Months Ended
	Jun. 30, 2014
Common Stock [Abstract]	'
Common Stock	'
	NOTE 5 – Common Stock
	The total number of common shares authorized that may be issued by the Company is 75,000,000 shares with a par value of $0.001 per share.
	As of June 30, 2014 and December 31, 2013, the Company had 36,443,119 shares of its common stock issued and outstanding.

Preferred_Stock

Preferred Stock	6 Months Ended
	Jun. 30, 2014
Preferred Stock [Abstract]	'
Preferred Stock	'
	NOTE 6 – Preferred Stock
	The total number of preferred shares authorized that may be issued by the Company is 5,000,000 shares with a par value of $0.001 per share.
	As of June 30, 2014 and December 31, 2013, the Company had no shares of its preferred stock issued and outstanding.

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	6 Months Ended
	Jun. 30, 2014
Recent Accounting Pronouncements [Abstract]	'
Recent Accounting Pronouncements	'
	NOTE 7 – Recent Accounting Pronouncements
	ASU 2014-10, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements”. ASU 2014-10 eliminates the distinction of a development stage entity and certain related disclosure requirements, including the elimination of inception-to-date information on the statements of operations, cash flows and stockholders’ equity. The amendments in ASU 2014-10 will be effective prospectively for annual reporting periods beginning after December 15, 2014, and interim periods within those annual periods, however early adoption is permitted. The Company evaluated and adopted ASU 2014-10 for the interim reporting period ended June 30, 2014.
	The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial statements.

Commitment

Commitment	6 Months Ended
	Jun. 30, 2014
Commitment [Abstract]	'
Commitment	'
	NOTE 8 – Commitment
	On April 4, 2014 the Company entered into a memorandum of understanding (the “MOU”) with Dr. Kiril Pandelisev and Yan Lawrence. Under the MOU, Dr. Pandelisev and Ms. Lawrence were to provide certain services to the Company and the Company was to have issued 10% of the issued and outstanding shares of the Company’s common stock to each of Dr. Pandelisev and Ms. Lawrence upon the completion of a reverse merger with a previously identified operating company, which reverse merger will not take place. Pursuant to ASC 505-50, the Company did not recognize any expense during the period since the issuance of these shares is contingent upon the completion of a specific merger. Accordingly, no performance commitment has been reached nor has performance been completed.

Subsequent_Events

Subsequent Events	6 Months Ended
	Jun. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	NOTE 9 – Subsequent Events
	The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined there are no additional events required to be disclosed.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2014
Summary of Significant Accounting Policies [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The accompanying financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (US GAAP) for financial information and in accordance with the Securities and Exchange Commission’s (SEC) Regulation S-X. They reflect all adjustments which are, in the opinion of the Company’s management, necessary for a fair presentation of the financial position and operating results as of and for the three and six months ended June 30, 2014, and 2013.
Use of Estimates	'
	Use of Estimates
	The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. As of June 30, 2014, and December 31, 2013 the Company had no cash equivalents.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	ASC 820, “Fair Value Measurements” and ASC 825, Financial Instruments, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. It establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. It prioritizes the inputs into three levels that may be used to measure fair value:
	Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
	Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
	As of June 30, 2014 and December 31, 2013 we believe that the recorded values of all of our financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.
	Description	Level 1	Level 2	Level 3	Total Realized Loss
	30-Jun-14	-	-	-	-
	31-Dec-13	-	-	-	-
	Totals	-	-	-	-
Net Loss Per Share Calculation	'
	Net Loss per Share Calculation
	Basic net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per shares is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. During the three and six month periods ended June 30, 2014 and 2013, the Company had no dilutive financial instruments issued or outstanding.
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes pursuant to FASB ASC 740, Income Taxes. Under FASB ASC 740-10-25, deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences.
	The Company maintains a valuation allowance with respect to deferred tax assets. China Herb Group Holdings Corporation establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws.
	Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about its ability to realize the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.
Prepaid Expenses	'
	Prepaid Expenses
	Prepaid expenses relates to cash paid in advance for legal services. These amounts are recognized as expense over the service period.
Fiscal Year	'
	Fiscal Year
	The Company elected December 31st for its fiscal year end.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2014
Summary of Significant Accounting Policies [Abstract]	'
Summary of financial instruments of fair value current	'
	Description	Level 1	Level 2	Level 3	Total Realized Loss
	30-Jun-14	-	-	-	-
	31-Dec-13	-	-	-	-
	Totals	-	-	-	-

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details Narrative) (USD $)	6 Months Ended	12 Months Ended
	Jun. 30, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total Realized Loss	'	'
Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total Realized Loss	'	'
Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total Realized Loss	'	'
Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Total Realized Loss	'	'

Going_Concern_Details_Narrativ

Going Concern (Details Narrative) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Going Concern [Abstract]	'	'
Cash and cash equivalents	$2,202	$32,143
Accumulated deficit	($189,064)	($124,233)

Related_Party_Transactions_Det

Related Party Transactions (Details Narrative) (USD $)	3 Months Ended	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Related Party Transactions [Abstract]	'	'	'	'
Due to President, CEO, director and shareholder of the Company	$57,100	$57,100	$3,000	$20,000
Interest Expense	$1,700	$2,787	'	'

Common_Stock_Details_Narrative

Common Stock (Details Narrative) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Common Stock [Abstract]	'	'
Common Stock, Shares Authorized	75,000,000	75,000,000
Common Stock, Par Value	$0.00	$0.00
Common Stock, Shares Issued	36,443,119	36,443,119
Common Stock, Shares Outstanding	36,443,119	36,443,119

Preferred_Stock_Details_Narrat

Preferred Stock (Details Narrative) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Preferred Stock [Abstract]	'	'
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0

Commitment_Details_Narrative

Commitment (Details Narrative)	6 Months Ended
	Jun. 30, 2014
Commitment [Abstract]	'
Commitment description	'The Company entered into a memorandum of understanding (the "MOU") with Dr. Kiril Pandelisev and Yan Lawrence. Under the MOU, Dr. Pandelisev and Ms. Lawrence will provide certain services to the Company and the Company will issue 10% of the issued and outstanding shares of the Company's common stock to each of Dr. Pandelisev and Ms. Lawrence.